BrightInsight, the leading platform for biopharma digital health solutions, will be hosting a reception at our booth (#2246) on Monday, Oct 9th at 4pm. Stop by for swag and giveaways. And we'll be providing demos of the BrightInsight Platform and Disease Management Solution at the booth throughout the conference. Come by to learn why bioMérieux, CSL Behring and other top biopharma companies rely on us to accelerate time to market for their digital initiatives.
BrightInsight replaces the need for lengthy and complicated ‘build from scratch’ implementations and instead offers a pre-built and proven platform designed under a Quality Management System to support global security, privacy, and regulatory requirements.
The world’s leading biopharma companies trust the BrightInsight Platform for their regulated digital health products including apps, algorithms, medical devices, connected combination products, diagnostics, and Software as a Medical Device (SaMD).
"We have found in BrightInsight a partner who shares our commitment to advancing public health with innovative, customer-centric solutions. Our engagement with BrightInsight will enable us to bring our digital health solutions to market faster with the goal of improving patient outcomes."
Brian Armstrong, Senior Vice President, Clinical Operations – North America, bioMérieux
Learn More
"After conducting a rigorous evaluation, we selected BrightInsight because it has the only regulated solution with a robust Quality Management System and a comprehensive list of privacy and security certifications. BrightInsight’s Platform allows us to focus on therapeutic innovation, rather than the underlying digital technology."
Brian Johnson, Director, Digital Health, CSL Behring
Case Study
"If you leverage a solution like BrightInsight that meets the most stringent requirements and maintains compliance as part of their managed service, you don’t have to worry about your regulated digital solutions in the U.S. versus Europe versus U.K. and so on. You just know they’re compliant."
Paul Upham, Head of Smart Devices, Roche/Genentech
Learn More